Integra Lifesciences
(IART)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 198,911 | 138,838 | 174,935 | 102,055 | 52,205 |
| Receivables | 275,296 | 265,737 | 251,799 | 148,186 | 132,241 |
| Inventories | 316,054 | 280,347 | 296,332 | 217,263 | 211,429 |
| TOTAL | $858,168 | $775,082 | $822,146 | $495,170 | $438,495 |
| Non-Current Assets | |||||
| PPE Net | 337,404 | 300,112 | 269,251 | 222,369 | 205,181 |
| Intangibles | 1,985,871 | 2,005,971 | 2,097,532 | 1,071,746 | 1,116,129 |
| Other Non-Current Assets | 121,797 | 26,722 | 22,328 | 18,669 | 14,419 |
| TOTAL | $2,445,072 | $2,332,805 | $2,389,111 | $1,312,784 | $1,335,729 |
| Total Assets | $3,303,240 | $3,107,887 | $3,211,257 | $1,807,954 | $1,774,224 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 113,090 | 76,050 | 93,967 | 29,057 | 34,772 |
| Accrued Expenses | 156,194 | 160,238 | 161,100 | 87,732 | 84,314 |
| Other current liabilities | 4,772 | 3,764 | 22,793 | N/A | N/A |
| TOTAL | $331,309 | $262,552 | $348,911 | $123,601 | $139,127 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,303,061 | 1,210,513 | 1,781,142 | 665,000 | 481,875 |
| Deferred Revenues | N/A | N/A | 11,051 | 6,812 | 5,666 |
| Other Non-Current Liabilities | 215,581 | 201,248 | 53,768 | 30,745 | 246,888 |
| TOTAL | $1,555,195 | $1,469,539 | $1,900,040 | $844,686 | $883,654 |
| Total Liabilities | $1,886,504 | $1,732,091 | $2,248,951 | $968,287 | $1,022,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,443 | 85,229 | 78,494 | 74,816 | 74,001 |
| Common Shares | 887 | 880 | 813 | 777 | 917 |
| Retained earnings | 398,574 | 348,373 | 285,186 | 220,443 | 145,879 |
| Other shareholders' equity | -76,345 | -45,058 | -23,451 | -57,205 | -48,023 |
| TOTAL | $1,416,736 | $1,375,796 | $962,306 | $839,667 | $751,443 |
| Total Liabilities And Equity | $3,303,240 | $3,107,887 | $3,211,257 | $1,807,954 | $1,774,224 |